Cite
HARVARD Citation
Jiménez-Yuste, V. et al. (2022). Clinical Efficacy and Safety of Fanhdi®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. Clinical and applied thrombosis/hemostasis. p. . [Online].